
Collaboration with Mayo Clinic Platform_Accelerate in the U.S. to enhance healthcare startups' entry into the U.S. market
We are pleased to announce that 12 startups have been selected to participate in the first phase (Phase 1) of the "J-StarX AI Medical Course" (formerly J-StarX HealthTech Gateway "AI Medical in the US"), which is being implemented by JETRO in cooperation with the Ministry of Economy, Trade and Industry. The 12 startup companies that will participate in the first phase (Phase 1) of the "J-StarX AI Medical Course" (formerly J-StarX HealthTech Gateway "AI Medical in the US"), which is conducted in cooperation with METI.
This program started in FY2024 as an acceleration program to support digital health startups, including those utilizing AI, to enter the U.S. market. The program aims to create healthcare startups that take on global challenges by providing practical support for understanding regulations, acquiring knowledge, formulating strategies, and building evidence, which are necessary for overseas expansion in the medical healthcare field in different regions.
In addition to the Mayo Clinic Platform, the platform organization of the Mayo Clinic, a world-class medical institution based in Minnesota, USA, and Kicker Ventures, a US venture capital firm, this year's program, the second in the series following last year, will be conducted in collaboration with the Mayo Clinic Berg Innovation Exchange, a new venture capital firm. In addition to the Mayo Clinic Platform, the platform organization of Mayo Clinic, a global medical institution based in the state of Utah, and Kicker Ventures, a venture capital firm in the U.S., we will collaborate with the Mayo Clinic Berg Innovation Exchange. This will strengthen the connection with KOLs (Key Opinion Leaders) such as clinicians within Mayo Clinic even more than in the previous fiscal year.
List of Adopted Companies
| AISI X | AISI X is a platform that uses AI to analyze brain images, tests, and medical history to diagnose brain disorders 10 times faster. | www.aisi-x.com |
| Godot, Inc. | Godot combines behavioral science and AI to precisely model human decision-making and behavior. It achieves patient-centered medicine and improved adherence, and leads the international medical DX with "reliable AI" that was the first to obtain ISO/IEC 42001 in Japan. | https://godot.inc |
| GramEye Inc. | Tackling the growing global problem of drug-resistant bacteria, GramEye is using AI medical devices to speed up the diagnosis of infectious diseases and optimize treatment options. GramEye aims to be an international flagship company that protects lives and economies. | https://grameye.com |
| HUMANITY VISION LLC | Humanity Vision provides an innovative platform that captures pupil movement to the nearest 0.1 mm by means of a smartphone face camera. | https://humanity-vision.io |
| LIFESCAPES Corporation | Brain-Computer Interface" that draws out the plasticity of the brain by "EEG x AI" is developed. It is a medical AI startup that aims to maximize QoL of central nervous system diseases from improvement of severe paralysis. | https://lifescapes.jp |
| NONAT Corporation | We are working on the establishment of a basic model specialized for women and children, and are promoting research and development related to "premature birth, stillbirth, and neonatal death" as the first project to apply such a model. | https://nonat-home.com |
| Surg storage Co. | Surg Storage provides anonymous and structured medical video and image data domestically and internationally. We partner with more than 120 hospitals, including the National Cancer Center, to support the development of high-quality medical AI and regulatory compliance. | https://www.surgstorage.com |
| SyntheticGestalt K.K. | SyntheticGestalt is a company that develops AI technology specialized for molecular information. We have developed the world's largest molecule-specific infrastructure model to solve the accuracy issues of conventional molecule-related AI. Through the use of AI in a wide range of fields such as pharmaceuticals, cosmetics, agrochemicals, and new materials, we aim to realize innovative inventions. | https://syntheticgestalt.com/ja |
| Soundwave Innovation Inc. | We are developing a minimally invasive treatment platform technology using low-intensity pulsed ultrasound ("LIPUS"). We are aiming for social implementation of medical devices that will bring revolutionary changes in the treatment of dementia, severe angina pectoris, arrhythmia, and other conditions. | https://sw-innovation.com |
| Digirehab Corporation | With the mission of "implementing a future unaffected by disability," we are developing and promoting "Digi-Rehab," a rehabilitation and rehabilitation tool that utilizes digital art and sensing systems. | https://www.digireha.com |
| TENCOO Corporation | We are contributing to clinical practice by providing medical institutions with our AI-based "Chrovis" (Chrovis) service to support diagnosis, treatment selection, and interpretation in cancer genome medicine. In the future, we will promote business development with a view to U.S. expansion. | https://xcoo.co.jp |
| NeoCure Inc. | This technology will provide real-time data to the front lines of global medicine, from emergency care to telemedicine, opening up new possibilities to save lives. | https://neocure.jp/ |
Program Overview
A two-stage acceleration program to support the digital health sector, including AI, in partnership with the Mayo Clinic Group, which has the largest patient data network in the U.S., among others.
▶Program page:https://www.jetro.go.jp/services/j-starx/b215.html
Phase 1: Basic Program (September - December 2025 approx.)
A lecture-, workshop-, and mentoring-centered online program designed to foster a mindset and strengthen strategy formulation skills for entering the U.S. market. During the final week, participants will visit the Mayo Clinic campus in Minnesota to deepen local understanding and be matched with a KOL.
Phase 2: Medical Data Utilization Program (February to September 2026 approx.)
Up to four health tech startups with AI-powered devices or products will have access to the Mayo Clinic Platform's medical data platform for 30 weeks. Anonymized medical data from millions of people will be used to help validate and improve AI models, build evidence, and enter the U.S. market.
Jamie Sundsbak, Director, Mayo Clinic Platform_Accelerate, said,
The J-StarX HealthTech Gateway program is an innovative bridge between Japanese innovation and the U.S. healthcare ecosystem. We are proud to be working with JETRO to support leading Japanese startups looking to expand their presence in the U.S. market. commented Mr. Kato.
Introduction of Partner Institutions
Mayo Clinic Platform
A digital health initiative founded on Mayo Clinic's patient-centered philosophy to innovate healthcare quality and research. Through collaboration with medical technology innovators, we aim to create new knowledge, solutions, and technologies to achieve a healthier world.
Details
Kicker Ventures
Kicker Ventures is a U.S.-based early-stage venture capital firm with over 20 years of investment experience and expertise in supporting innovative startups in the crossover areas of advanced technology and healthcare/life sciences under the theme of "Healthcare of the Future. We support innovative startups in the crossover areas of cutting-edge technology and healthcare/life sciences. We work closely with entrepreneurs through our unique value creation platform to accelerate business growth and achieve sustainable value and impact in the global marketplace.
Details
Mayo Clinic Berg Innovation Exchange
An advanced platform that accelerates innovative ideas that address the most critical issues in healthcare into practical and scalable solutions. Based on the Mayo Model of Care, a patient-centered, multi-professional collaboration, we provide support for funding, validation, testing, and implementation.
Details
About JETRO
JETRO (Japan External Trade Organization) aims to contribute to the further development of the Japanese economy and society through trade and investment promotion and research on developing countries.
Utilizing its headquarters in Tokyo and Osaka, approximately 50 domestic offices, more than 70 overseas offices around the world, and the Research Institute of Economy, Trade and Industry (RIETI), the Institute supports innovation creation, exports of agricultural, forestry, and fishery products, and overseas expansion of small and medium-sized enterprises. We also conduct surveys and research on corporate activities and trade policies.
In recent years, in line with the government's "Five-Year Plan for Startup Development," the government has been strongly promoting support for startups' overseas expansion.
Details
Japan External Trade Organization (JETRO) Startup Division|Outline
| name of company | Startup Division, Japan External Trade Organization (JETRO) |
| Location | 7F Ark Mori Building, 1-12-32 Akasaka, Minato-ku, Tokyo |
| representative | Noriya Tarutani |
| uniform resouce locator | https://www.jetro.go.jp/theme/innovation/startup_menu.html |









